Skip to main content
. 2017 Oct 24;26(2):92–101. doi: 10.1016/j.tim.2017.09.011

Table 1.

Key Table

Secretor Status Profoundly Influences Infection and Disease Susceptibilitya

Infection Secretors more susceptible Nonsecretors more susceptible Refs
Norovirus (GII.4) 21, 74
Rotavirus (VP8) 36, 37, 38
Influenza A virus [19]
Rhinovirus [19]
Echovirus [19]
RSV [19]
HIV 16, 17, 18
Helicobacter pylori 24, 75, 76
Candida albicans 77, 78
Streptococcus pneumoniae [22]
Neisseria meningitidis [22]
Haemophilus influenzae [23]
Salmonella enterica serovar Typhimuriumb [11]
Citrobacter rodentiumb [9]
Campylobacter jejuni 41, 42
Urinary tract infection 79, 80
Bacteraemia (after haematopoietic stem cell transplantation) [81]
Disease Secretors more susceptible Nonsecretors more susceptible Refs
Non-CF bronchiectasis severityc [67]
Asthma severity [82]
Graft-versus-host disease [81]
Intestinal-type gastric cancer [83]
Primary sclerosing cholangitis [84]
Crohn’s disease 53, 85
Celiac disease [86]
Asthma 26, 27
Type 1 diabetes [28]
High plasma vitamin B12 87, 88, 89
Chronic pancreatitis [25]
Psoriasis [29]
Acute uncomplicated pyelonephritis [90]
Behçet’s disease [91]
a

Secretor phenotype is associated with increased susceptibility to viral infections and respiratory disease severity, but with decreased susceptibility to bacterial infections and a diverse range of chronic inflammatory diseases.

b

Demonstrated in Fut2–/– mice with no human epidemiological evidence.

c

Abbreviation: CF, cystic fibrosis.